Synthesis and the antimicrobial activity of 1-alkyl-5-methyl-3-phenyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-diones

S. V. Vlasov, T. P. Osolodchenko, S. M. Kovalenko, V. P. Chernykh


An effective approach for synthesis of 5-methyl-3-phenyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione by 1,1’-carbonyldiimidazole promoted interaction of 5-methyl-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carboxylic acid with benzohydrazide has been developed. The procedure also includes cyclization of N’-benzoyl-5-methyl-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidine-6-carbohydrazide obtained by boiling in phosphorous oxychloride and further hydrolysis of the chlorine atom at position 2 of the thieno[2,3-d]pyrimidine system. Alkylation of the assembly of two heterocyclic units obtained with benzyl chlorides, chloroacetamides, and 5-(chloromethyl)-3-aryl-1,2,4-oxadiazoles has allowed obtaining of 1-alkyl-5-methyl-3-phenyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-diones. The structures of the compounds obtained have been confirmed by the 1H NMR, chromato-mass spectral and elemental microanalysis data. The results of the screening performed by the agar diffusion method (“well method”) have shown the absence of the antimicrobial activity for 1-benzyl-5-methyl-3-phenyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-diones and 2-[5-methyl-2,4-dioxo-3-phenyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)-3,4-dihydrothieno[2,3-d]pyrimidin-1(2H)-yl]-N-arylacetamides; but the activity for 1-{[3-aryl-1,2,4-oxadiazol-5-yl]methyl}-5-methyl-3-phenyl-6-(5-phenyl-1,3,4-oxadiazol-2-yl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-diones has been found. The compounds of this range appeared to be active against the strains of Staphylococcus aureus, Escherichia coli and Bacillus subtilis; the diameters of their growth inhibition zones were similar to those for the reference drugs Metronidazole and Streptomycin.


thiophene; pyrimidine; alkylation

Full Text:



Пат. US 20070208040 (2007) // заявл.: 02.03.2007; опубл.: 06.09.2007. [Электронный ресурс] Режим доступа

Власов С.В., Заремба О.В., Коваленко С.М., Федосов А.І., Черних В.П. // ЖОрФХ. – 2011. – Т. 9, №4 (36). – С. 24-30.

Kotaiah Y., Harikrishna N., Nagaraju K., Venkata Rao C. // Eur. J. Med.Chem. — 2012. — Vol. 58. — P. 340-345.

Vlasov S. V., Kovalenko S. M., Chernykh V. P., Krolenko K. Yu. // J. Chem. Pharm. Res. – 2014. – Vol.6, № 6. – Р. 22-27.

Власов С.В., Коваленко С.М., Черних В.П. // ЖОрФХ. – 2013. – Т. 11, №2 (42). – С. 41-46.

Власов С.В., Коваленко С.М., Федосов А.І., Черних В.П. // ЖОрФХ. – 2011. – Т. 9, №3(35). – С. 51-55.

Ткаченко О.В., Власов С.В., Свєчнікова О.М., Журавель А.В. // Управління, економіка та забезпечення якості в фармації. – 2013. – № 3(29). – с. 23-28.

Sasaki S., Cho N., Nara Y., et al // J. Med. Chem. – 2003. – Vol. 46, №1. P. 113–124.

Ogawva K, Yamawaki, Matsusita YI et al. // Eur. J. Med. Chem. –1993.– Vol. 28, №10. – 769-781.

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Document M100-S22, Vol. 32, No. 3, CLSI, Wayne, PA, January, 2012.

American Society for Microbiology, Coyle M.B. Manual of Antimicrobial Susceptibility Testing. American Society for Microbiology: Washington; 2005, p 236.

GOST Style Citations

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: J. Org. Pharm. Chem.

ISSN 2518-1548 (Online), ISSN 2308-8303 (Print)